Spots Global Cancer Trial Database for gene expression analysis
Every month we try and update this database with for gene expression analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy | NCT01153672 | Male Breast Can... Recurrent Breas... Stage IV Breast... | vorinostat laboratory biom... biopsy F-18 16 alpha-f... positron emissi... anastrozole letrozole exemestane gene expression... | 18 Years - | University of Washington | |
| Biomarkers in Patients With Head and Neck Cancer | NCT01466257 | Head and Neck C... | cetuximab cisplatin DNA analysis gene expression... mutation analys... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia | NCT01229956 | Leukemia | DNA methylation... gene expression... microarray anal... reverse transcr... laboratory biom... | 1 Year - 18 Years | Children's Oncology Group | |
| Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation | NCT00052520 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... B-cell Adult Ac... B-cell Childhoo... Childhood Chron... Childhood Myelo... Chronic Myelomo... Essential Throm... Polycythemia Ve... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Child... Recurrent Child... Refractory Anem... Refractory Anem... Relapsing Chron... Secondary Acute... T-cell Adult Ac... T-cell Childhoo... | therapeutic all... aldesleukin peripheral bloo... allogeneic bone... laboratory biom... gene expression... immunologic tec... flow cytometry polymerase chai... cytogenetic ana... staining method | - | Fred Hutchinson Cancer Center | |
| Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT00482495 | Multiple Myelom... | bevacizumab gene expression... protein express... laboratory biom... | 18 Years - | Mayo Clinic | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | NCT00967889 | Prostate Cancer | gene expression... protein analysi... biologic sample... laboratory biom... | - | National Cancer Institute (NCI) | |
| Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | NCT00601406 | Breast Cancer Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... Prostate Cancer Sarcoma Vaginal Cancer Vulvar Cancer | gene expression... gene rearrangem... polymorphism an... laboratory biom... radiation thera... | - | National Cancer Institute (NCI) | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Oral HPV Infection in Young Men | NCT00897273 | Head and Neck C... Infection Precancerous Co... | comparative gen... gene expression... study of socioe... evaluation of c... study of high r... | 18 Years - 21 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00550784 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim cisplatin cyclophosphamid... melphalan paclitaxel topotecan hydro... TdT-mediated dU... gene expression... immunohistochem... pharmacological... peripheral bloo... | - 60 Years | City of Hope Medical Center | |
| Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45 | NCT00914043 | Breast Cancer Fatigue | gene expression... microarray anal... polymerase chai... polymorphism an... reverse transcr... biologic sample... enzyme-linked i... laboratory biom... fatigue assessm... | - | NSABP Foundation Inc | |
| Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 | NCT01407757 | Leukemia | DNA analysis gene expression... laboratory biom... pharmacogenomic... | - 29 Years | Children's Oncology Group | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin | NCT01120262 | Prostate Cancer | gene expression... polymorphism an... laboratory biom... | 18 Years - 120 Years | SWOG Cancer Research Network | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide | NCT00899080 | Multiple Myelom... | gene expression... reverse transcr... immunoenzyme te... laboratory biom... platelet aggreg... | - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy | NCT01194635 | Head and Neck C... | fluorescence in... gene expression... polymerase chai... protein analysi... protein express... enzyme-linked i... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors | NCT01544569 | Kidney Cancer | DNA analysis fluorescence in... gene expression... gene mapping microarray anal... polymerase chai... protein express... laboratory biom... medical chart r... | - 1 Year | Children's Oncology Group | |
| Assessment of Candidate Protein Expression in Breast Cancer Specimens | NCT00918892 | Breast Cancer | gene expression... immunohistochem... laboratory biom... | - | Case Comprehensive Cancer Center | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524 | NCT00898820 | Lung Cancer | gene expression... polymorphism an... protein express... | 18 Years - | Mayo Clinic | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin | NCT01503541 | Leukemia | DNA analysis RNA analysis gene expression... mutation analys... polymerase chai... laboratory biom... | 18 Years - 88 Years | SWOG Cancer Research Network | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia | NCT01338974 | Leukemia | gene expression... proteomic profi... flow cytometry laboratory biom... | 56 Years - | SWOG Cancer Research Network | |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma | NCT00942422 | Multiple Myelom... Precancerous Co... | defined green t... gene expression... protein analysi... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases. | NCT05634889 | Breast Cancer | De-escalation | 18 Years - | Region Skane | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 | NCT01430637 | Sarcoma | DNA analysis RNA analysis gene expression... mutation analys... nucleic acid se... polymerase chai... laboratory biom... pharmacogenomic... | - 50 Years | Children's Oncology Group | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma | NCT01390571 | Brain and Centr... | olaparib temozolomide gene expression... protein express... laboratory biom... pharmacological... diffusion-weigh... dynamic contras... therapeutic con... | 18 Years - | Cancer Research UK | |
| Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 | NCT00544804 | Breast Cancer Metastatic Canc... | lapatinib ditos... gene expression... diagnostic labo... | 18 Years - | University of California, San Francisco | |
| DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer | NCT00898664 | Head and Neck C... | cytogenetic ana... gene expression... mutation analys... polymerase chai... immunohistochem... laboratory biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery | NCT00541073 | Malignant Mesot... | vitamin B12 cisplatin pemetrexed diso... gene expression... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | NCT00967889 | Prostate Cancer | gene expression... protein analysi... biologic sample... laboratory biom... | - | National Cancer Institute (NCI) | |
| S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia | NCT01434329 | Leukemia | DNA methylation... gene expression... microarray anal... laboratory biom... medical chart r... | 18 Years - | SWOG Cancer Research Network | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | NCT01270880 | Adenocarcinoma ... Hormone-resista... Recurrent Prost... Stage IV Prosta... | Hsp90 inhibitor... laboratory biom... polymerase chai... enzyme-linked i... RNA analysis spectrophotomet... reverse transcr... gene expression... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00390403 | Brain and Centr... | R-(-)-gossypol ... temozolomide gene expression... mutation analys... protein express... laboratory biom... pharmacological... adjuvant therap... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer | NCT00415298 | Head and Neck C... | DACH polymer pl... oxaliplatin gene expression... immunohistochem... pharmacological... biopsy | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | NCT00454480 | Leukemia Myelodysplastic... | alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ... | - | National Cancer Institute (NCI) | |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| DNA Analysis in Influencing Response to Rituximab in Samples From Patients With Follicular Lymphoma Treated on ECOG-E4402 | NCT01406782 | Lymphoma | rituximab DNA analysis gene expression... polymerase chai... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma | NCT00691652 | Lymphoma | rituximab clofarabine DNA methylation... gene expression... microarray anal... polymerase chai... high performanc... laboratory biom... | 18 Years - 89 Years | OHSU Knight Cancer Institute | |
| Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | NCT01553448 | Neoplastic Synd... Neuroblastoma | gene expression... protein express... enzyme-linked i... immunohistochem... laboratory biom... medical chart r... | - 21 Years | Children's Oncology Group | |
| Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer | NCT00083083 | Lung Cancer | carboplatin cisplatin docetaxel etoposide paclitaxel vinblastine sul... vinorelbine tar... gene expression... positron emissi... fludeoxyglucose... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | NCT00967954 | Prostate Cancer | antiandrogen th... releasing hormo... DNA analysis RNA analysis comparative gen... gene expression... laboratory biom... diffusion-weigh... magnetic resona... | - | National Cancer Institute (NCI) | |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast | NCT00536718 | Breast Cancer | gene expression... molecular diagn... polymorphism an... protein express... medical chart r... questionnaire a... | - 60 Years | National Cancer Institute (NCI) | |
| Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | NCT00538291 | Colorectal Canc... | cetuximab capecitabine gene expression... microarray anal... polymorphism an... reverse transcr... immunohistochem... | 18 Years - | City of Hope Medical Center | |
| Biomarkers in Patients With Rhabdomyosarcoma | NCT01466283 | Sarcoma | DNA methylation... fluorescence in... gene expression... reverse transcr... laboratory biom... | - | Children's Oncology Group | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | NCT00977457 | Prostate Cancer | DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | NCT00770185 | Endometrial Can... | ridaforolimus gene expression... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | NCT00617799 | Kidney Cancer Melanoma (Skin) | aldesleukin gene expression... mutation analys... flow cytometry | 19 Years - 120 Years | University of Nebraska | |
| Studying Blood Samples From Women With Breast Cancer or Ductal Carcinoma In Situ Who Are Receiving Tamoxifen | NCT00764322 | Breast Cancer Menopausal Symp... | tamoxifen citra... gene expression... pharmacogenomic... questionnaire a... quality-of-life... | 21 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases | NCT00450983 | Graft Versus Ho... Leukemia Myelodysplastic... | muromonab-CD3 natural killer ... fludarabine pho... methotrexate thiotepa gene expression... flow cytometry immunologic tec... allogeneic hema... in vitro-treate... total-body irra... | - 45 Years | Fred Hutchinson Cancer Center | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma | NCT00942422 | Multiple Myelom... Precancerous Co... | defined green t... gene expression... protein analysi... laboratory biom... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Panitumumab and Irinotecan as Third-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | NCT00655499 | Colorectal Canc... | Panitumumab Irinotecan hydr... Chromogenic in ... Fluorescence in... Gene expression... Laboratory biom... | 18 Years - 80 Years | GERCOR - Multidisciplinary Oncology Cooperative Group | |
| Biomarkers in Tissue Samples From Patients With Ductal Breast Carcinoma in Situ | NCT01132560 | Breast Cancer | RNA analysis gene expression... reverse transcr... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202 | NCT00990873 | Lung Cancer | gene expression... microarray anal... reverse transcr... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma | NCT00896519 | Lymphoma | rituximab sargramostim cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... gene expression... gene rearrangem... polymerase chai... R-CHOP regimen laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507 | NCT00907699 | Lung Cancer | DNA analysis RNA analysis fluorescence in... gene expression... mutation analys... polymerase chai... reverse transcr... laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors | NCT00878904 | Unspecified Adu... | epirubicin hydr... panobinostat gene expression... protein express... western blottin... immunologic tec... laboratory biom... pharmacological... | 18 Years - 120 Years | University of California, San Francisco | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
